Global Intravenous Immunoglobulin Market 2026 -
Players, Regions, Product Types, Application & Forecast Analysis
Global Intravenous Immunoglobulin Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis
| Pharma & Healthcare | Formats |
| Updated: March 2026 | 4.6 (73) |
Chapter 1 Intravenous Immunoglobulin Market Overview
1.1 Intravenous Immunoglobulin Definition
1.2 Global Intravenous Immunoglobulin Market Size Status and Outlook (2019-2032)
1.3 Global Intravenous Immunoglobulin Market Size Comparison by Region (2019-2032)
1.4 Global Intravenous Immunoglobulin Market Size Comparison by Type (2019-2032)
1.5 Global Intravenous Immunoglobulin Market Size Comparison by Application (2019-2032)
1.6 Global Intravenous Immunoglobulin Market Size Comparison by Sales Channel (2019-2032)
1.7 Intravenous Immunoglobulin Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
1.7.6 US-Israel-Iran War Impacts
Chapter 2 Executive Summary
2.1 Global Intravenous Immunoglobulin Market Snapshot
2.2 Global Intravenous Immunoglobulin Market Volume & Revenue (2019-2025)
2.3 Global Intravenous Immunoglobulin Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)
2.4 Global Intravenous Immunoglobulin Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)
2.5 Global Intravenous Immunoglobulin Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)
2.6 Global Intravenous Immunoglobulin Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)
Chapter 3 Intravenous Immunoglobulin Market Segment Analysis by Player
3.1 Global Intravenous Immunoglobulin Sales and Market Share by Player (2023-2025)
3.2 Global Intravenous Immunoglobulin Revenue and Market Share by Player (2023-2025)
3.3 Global Intravenous Immunoglobulin Average Price by Player (2023-2025)
3.4 Players Competition Situation & Trends (2023-2025)
3.5 Conclusion of Segment by Player
Chapter 4 Intravenous Immunoglobulin Market Segment Analysis by Type
4.1 Global Intravenous Immunoglobulin Market by Type
4.1.1 IVIg Liquid
4.1.2 IVIg Powder
4.2 Global Intravenous Immunoglobulin Sales and Market Share by Type (2019-2025)
4.3 Global Intravenous Immunoglobulin Revenue and Market Share by Type (2019-2025)
4.4 Global Intravenous Immunoglobulin Average Price by Type (2019-2025)
4.5 Leading Players of Intravenous Immunoglobulin by Type in 2025
4.6 Conclusion of Segment by Type
Chapter 5 Intravenous Immunoglobulin Market Segment Analysis by Application
5.1 Global Intravenous Immunoglobulin Market by Application
5.1.1 Immunodeficiency
5.1.2 Autoimmune Disease
5.1.3 Acute Infection
5.2 Global Intravenous Immunoglobulin Revenue and Market Share by Application (2019-2025)
5.3 Leading Consumers of Intravenous Immunoglobulin by Application in 2025
5.4 Conclusion of Segment by Application
Chapter 6 Intravenous Immunoglobulin Market Segment Analysis by Sales Channel
6.1 Global Intravenous Immunoglobulin Market by Sales Channel
6.1.1 Global Intravenous Immunoglobulin Market, by Direct Channel Market Analysis (2019-2032) (USD Million)
6.1.2 Global Intravenous Immunoglobulin Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)
6.2 Global Intravenous Immunoglobulin Revenue and Market Share by Sales Channel (2019-2025)
6.3 Leading Distributors/Dealers of Intravenous Immunoglobulin by Sales Channel in 2025
6.4 Conclusion of Segment by Sales Channel
Chapter 7 Intravenous Immunoglobulin Market Segment Analysis by Region
7.1 Global Intravenous Immunoglobulin Market Size and CAGR by Region (2019-2032)
7.2 Global Intravenous Immunoglobulin Sales and Market Share by Region (2019-2025)
7.3 Global Intravenous Immunoglobulin Revenue and Market Share by Region (2019-2025)
7.4 North America
7.4.1 North America Market by Country
7.4.2 North America Intravenous Immunoglobulin Market Share by Type
7.4.3 North America Intravenous Immunoglobulin Market Share by Application
7.4.4 United States
7.4.5 Canada
7.4.6 Mexico
7.5 Europe
7.5.1 Europe Market by Country
7.5.2 Europe Intravenous Immunoglobulin Market Share by Type
7.5.3 Europe Intravenous Immunoglobulin Market Share by Application
7.5.4 Germany
7.5.5 United Kingdom
7.5.6 France
7.5.7 Italy
7.5.8 Russia
7.5.9 Spain
7.5.10 Benelux
7.5.11 Poland
7.5.12 Austria
7.5.13 Portugal
7.5.14 Rest of Europe
7.6 Asia-Pacific
7.6.1 Asia-Pacific Market by Country
7.6.2 Asia-Pacific Intravenous Immunoglobulin Market Share by Type
7.6.3 Asia-Pacific Intravenous Immunoglobulin Market Share by Application
7.6.4 China
7.6.5 Japan
7.6.6 Korea
7.6.7 India
7.6.8 Southeast Asia
7.6.9 Australia
7.6.10 Taiwan
7.6.11 Rest of Asia Pacific
7.7 South America
7.7.1 South America Market by Country
7.7.2 South America Intravenous Immunoglobulin Market Share by Type
7.7.3 South America Intravenous Immunoglobulin Market Share by Application
7.7.4 Brazil
7.7.5 Argentina
7.7.6 Colombia
7.7.7 Chile
7.7.8 Peru
7.7.9 Venezuela
7.7.10 Rest of South America
7.8 Middle East & Africa
7.8.1 Middle East & Africa Market by Country
7.8.2 Middle East & Africa Intravenous Immunoglobulin Market Share by Type
7.8.3 Middle East & Africa Intravenous Immunoglobulin Market Share by Application
7.8.4 UAE
7.8.5 Saudi Arabia
7.8.6 South Africa
7.8.7 Egypt
7.8.8 Nigeria
7.9.9 Rest of Middle East & Africa
7.9 Conclusion of Segment by Region
Chapter 8 Profile of Leading Intravenous Immunoglobulin Players
8.1 Baxter
8.1.1 Company Snapshot
8.1.2 Product/Service Offered
8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.1.4 Recent Developments
8.2 Grifols
8.2.1 Company Snapshot
8.2.2 Product/Service Offered
8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.2.4 Recent Developments
8.3 CSL
8.3.1 Company Snapshot
8.3.2 Product/Service Offered
8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.3.4 Recent Developments
8.4 Octapharma
8.4.1 Company Snapshot
8.4.2 Product/Service Offered
8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.4.4 Recent Developments
8.5 Biotest
8.5.1 Company Snapshot
8.5.2 Product/Service Offered
8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.5.4 Recent Developments
8.6 Kedrion
8.6.1 Company Snapshot
8.6.2 Product/Service Offered
8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.6.4 Recent Developments
8.7 Hualan Bio
8.7.1 Company Snapshot
8.7.2 Product/Service Offered
8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.7.4 Recent Developments
8.8 CNBG
8.8.1 Company Snapshot
8.8.2 Product/Service Offered
8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.8.4 Recent Developments
8.9 Shanghai RAAS
8.9.1 Company Snapshot
8.9.2 Product/Service Offered
8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.9.4 Recent Developments
8.10 CBPO
8.10.1 Company Snapshot
8.10.2 Product/Service Offered
8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.10.4 Recent Developments
8.11 LFB Group
8.11.1 Company Snapshot
8.11.2 Product/Service Offered
8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.11.4 Recent Developments
8.12 BPL
8.12.1 Company Snapshot
8.12.2 Product/Service Offered
8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.12.4 Recent Developments
8.13 Sichuan Yuanda Shuyang
8.13.1 Company Snapshot
8.13.2 Product/Service Offered
8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.13.4 Recent Developments
Chapter 9 Upstream and Downstream Analysis of Intravenous Immunoglobulin
9.1 Industrial Chain of Intravenous Immunoglobulin
9.2 Upstream of Intravenous Immunoglobulin
9.2.1 Raw Materials (If Applicable)
9.2.2 Manufacturing Cost Structure (If Applicable)
9.2.3 Manufacturing Process (If Applicable)
9.3 Downstream of Intravenous Immunoglobulin
9.3.1 Leading Distributors/Dealers of Intravenous Immunoglobulin
9.3.2 Leading Consumers of Intravenous Immunoglobulin
Chapter 10. Global Intravenous Immunoglobulin Market Industry Analysis
10.1. Porter's Five Forces Analysis
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Buyers/Consumers
10.1.3. Bargaining Power of Suppliers
10.1.4. Threat of Substitute Types
10.1.5. Intensity of Competitive Rivalry
10.2. Major Growth Avenues within Global Intravenous Immunoglobulin Market
10.2.1. Product Types
10.2.2. Applications
10.2.3. Sales Channels
10.2.4. Country
10.3. Intravenous Immunoglobulin Industry Ecosystem
10.4. Price Trend Analysis (If Applicable)
10.5. Buying Criteria (If Applicable)
10.6. Regulations (If Applicable)
Chapter 11 Development Trend of Intravenous Immunoglobulin (2026-2032)
11.1 Global Intravenous Immunoglobulin Market Size (Sales and Revenue) Forecast (2026-2032)
11.2 Global Intravenous Immunoglobulin Market Size and CAGR Forecast by Region (2026-2032)
11.3 Global Intravenous Immunoglobulin Market Size and CAGR Forecast by Type (2026-2032)
11.4 Global Intravenous Immunoglobulin Market Size and CAGR Forecast by Application (2026-2032)
11.5 Global Intravenous Immunoglobulin Market Size and CAGR Forecast by Sales Channel (2026-2032)
Chapter 12. Import - Export Analysis (If Applicable)
12.1 North America Intravenous Immunoglobulin Import-Export (2019-2025)
12.2 Europe Intravenous Immunoglobulin Import-Export (2019-2025)
12.3 Asia Pacific Intravenous Immunoglobulin Import-Export (2019-2025)
12.4 South America Intravenous Immunoglobulin Import-Export (2019-2025)
12.5 Middle East & Africa Intravenous Immunoglobulin Import-Export (2019-2025)
Chapter 13. Demand-Supply Gap Analysis
13.1 North America Intravenous Immunoglobulin Demand-Supply (2019-2025)
13.2 Europe Intravenous Immunoglobulin Demand-Supply (2019-2025)
13.3 Asia Pacific Intravenous Immunoglobulin Demand-Supply (2019-2025)
13.4 South America Intravenous Immunoglobulin Demand-Supply (2019-2025)
13.5 Middle East & Africa Intravenous Immunoglobulin Demand-Supply (2019-2025)
Chapter 14 Appendix
14.1 Research Methodology
14.2 Data Sources
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.